Anticardiolipin antibodies in patients with rheumatoid arthritis and spondyloarthropathies treated with infliximab

被引：0
|
作者：
Gómez-Puerta, JA
Hernández, MV
Reverter, JC
Salvador, G
Vázquez, I
Graell, E
Rodriguez-Cros, JR
Gómez-Centeno, A
Cañete, JD
Sanmarti, R
机构：
[1] Hosp Clin Barcelona, Arthrit Unit, Dept Rheumatol, Barcelona, Spain
[2] Hosp Clin Barcelona, Haemostasia Dept, Barcelona, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2005年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：253 / 253
页数：1
相关论文
共 50 条
  • [21] Fertility in male patients with seronegative spondyloarthropathies treated with infliximab
    Saougou, Ioanna
    Markatseli, Theodora E.
    Papagoras, Charalampos
    Kaltsonoudis, Evripidis
    Voulgari, Paraskevi V.
    Drosos, Alexandros A.
    JOINT BONE SPINE, 2013, 80 (01) : 34 - 37
  • [22] PRESENCE OF ANTIBODIES TO ADALIMUMAB AND INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL REMISSION
    Eng, G.
    Fana, V.
    Omerovic, E.
    Hojsgaard, P.
    Lindegaard, H. M.
    Jensen, E. K.
    Bouchelouche, P. N.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 230 - 230
  • [23] Clinical Response in Rheumatoid Arthritis Patients with Anti-Infliximab Antibodies
    Opris, Daniela
    Mazilu, Diana
    Ionescu, Ruxandra
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S40 - S41
  • [24] Autoimmunity is not associated with antibodies to infliximab in patients with early rheumatoid arthritis.
    Rojas, JR
    Wagner, CL
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S568 - S569
  • [25] Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy
    De Rycke, L
    Kruithof, E
    Van Damme, N
    Hoffman, IEA
    Van den Bossche, N
    Van den Bosch, F
    Veys, EM
    De Keyser, F
    ARTHRITIS AND RHEUMATISM, 2003, 48 (04): : 1015 - 1023
  • [26] Infliximab treatment in patients with rheumatoid arthritis and spondyloarthropathies in one rheumatological center: two years' drug survival
    Levalampi, Tiina
    Korpela, Markku
    Vuolteenaho, Katriina
    Moilanen, Eeva
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (12) : 1611 - 1620
  • [27] Infliximab treatment in patients with rheumatoid arthritis and spondyloarthropathies in one rheumatological center: two years’ drug survival
    Tiina Levälampi
    Markku Korpela
    Katriina Vuolteenaho
    Eeva Moilanen
    Rheumatology International, 2010, 30 : 1611 - 1620
  • [28] The timing of serum infliximab loss, or the appearance of antibodies to infliximab (ATI), is related with the clinical activity in ATI-positive patients with rheumatoid arthritis treated with infliximab
    Plasencia, Ch
    Pascual-Salcedo, D.
    Alcocer, P.
    Bonilla, M. G.
    Villalba, A.
    Peiteado, D.
    Arribas, F.
    Diez, J.
    Lopez-Casla, M. T.
    Martin-Mola, E.
    Balsa, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (11) : 1888 - 1890
  • [29] THE EARLY INFLIXIMAB LEVELS MONITORING CAN PREDICT THE DEVELOPEMENT OF ANTI-DRUG ANTIBODIES IN A COHORT OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB
    Chamaida, P. -R.
    Pascual-Salcedo, D.
    Bonilla, M.
    Villalba, A.
    Lopez-Casla, M.
    Peiteado, D.
    Garcia-Carazo, S.
    Ramiro, S.
    Franco, K.
    Cajigas, D.
    Martin-Mola, E.
    Balsa, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 157 - 157
  • [30] Modification of neutrophil function by plasma of rheumatoid arthritis patients treated with infliximab
    Dain, L
    Braun-Moscovici, Y
    Baum, E
    Nahir, AM
    Hoffer, E
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (01) : 38 - 44
12345